Characterization of blood pressure signal considering low and high risk stratification in cardiomyopathy patients
06713497.pdf (802,1Kb) (Restricted access) Request copy
Què és aquest botó?
Aquest botó permet demanar una còpia d'un document restringit a l'autor. Es mostra quan:
- Disposem del correu electrònic de l'autor
- El document té una mida inferior a 20 Mb
- Es tracta d'un document d'accés restringit per decisió de l'autor o d'un document d'accés restringit per política de l'editorial
Document typeConference report
Rights accessRestricted access - publisher's policy
Ischemic and dilated cardiomyopathy are associated with disorders of myocardium. Using the blood pressure (BP) signal and the values of the ventricular ejection fraction, we obtained parameters for stratifying cardiomyopathy patients as low- and high-risk. We studied 48 cardiomyopathy patients characterized by NYHA '22: 19 patients with dilated cardiomyopathy (DCM) and 29 patients with ischemic cardiomyopathy (lCM). The left ventricular ejection fraction (LVEF) percentage was used to classify patients in low risk (LR: LVEF > 35%, 17 patients) and high risk (HR: LVEF::; 35%, 31 patients) groups. From the BP signal, we extracted the upward systolic slope (BPsl), the difference between systolic and diastolic BP (B P A), and systolic time intervals (ST I). When we compared the LR and HR groups in the time domain analysis, the best parameters were standard deviation (SD) of 1/ ST I, kurtosis (K) of B Psl, and K of B P A. In the frequency domain analysis, very low frequency (VLF) and high frequency (HF) bands showed statistically significant differences in comaprisons of LR and HR groups. The area under the curve of power spectral density was the best parameter in all classifications, and particularly in the very low- and high- frequency bands (p < 0.001). These parameters could help to improve the risk stratification of cardiomyopathy patients.
CitationArcentales, A. [et al.]. Characterization of blood pressure signal considering low and high risk stratification in cardiomyopathy patients. A: Computing in Cardiology. "Computing in Cardiology 2013". Zaragoza: 2013, p. 795-798.
All rights reserved. This work is protected by the corresponding intellectual and industrial property rights. Without prejudice to any existing legal exemptions, reproduction, distribution, public communication or transformation of this work are prohibited without permission of the copyright holder